Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-16

Clinical Trial Update: Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease [NA]

View source ↗

Summary

Clinical trial evaluating multi-strain probiotics for children and adolescents with inflammatory bowel disease. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Multi-Strain Probiotic Supplementation (probiotic mixture)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Inflamatory Bowel Disease | NA | Status: NOT_YET_RECRUITING